Vor Biopharma's total assets for Q4 2025 were $464.13M, an increase of 163.35% from the previous quarter. VOR total liabilities were $628.44M for the fiscal quarter, a -73.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.